| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 71.613 | 73.561 | 70.019 | 73.320 | 57.397 | 60.263 | 76.971 | 72.699 | 79.197 | 74.000 |
| Total Income - EUR | 72.189 | 74.733 | 70.238 | 73.320 | 57.397 | 60.288 | 77.118 | 72.699 | 80.594 | 74.000 |
| Total Expenses - EUR | 79.015 | 78.344 | 73.818 | 77.922 | 66.582 | 64.144 | 76.168 | 74.387 | 81.003 | 73.711 |
| Gross Profit/Loss - EUR | -6.826 | -3.611 | -3.580 | -4.602 | -9.185 | -3.856 | 950 | -1.689 | -409 | 289 |
| Net Profit/Loss - EUR | -6.826 | -3.611 | -3.580 | -7.071 | -9.759 | -4.429 | 180 | -2.416 | -1.215 | 289 |
| Employees | 7 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Pharma S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.579 | 39.766 | 35.657 | 31.639 | 27.721 | 23.953 | 21.493 | 20.622 | 19.376 | 18.246 |
| Current Assets | 57.337 | 55.631 | 55.720 | 52.055 | 42.187 | 40.317 | 42.001 | 42.504 | 43.302 | 43.395 |
| Inventories | 16 | 25 | 34 | 28 | 44 | 32 | 26 | 48 | 40 | 24 |
| Receivables | 37.815 | 34.271 | 34.334 | 30.823 | 30.147 | 30.629 | 29.850 | 29.209 | 31.090 | 33.449 |
| Cash | 19.505 | 21.335 | 21.352 | 21.204 | 11.996 | 9.656 | 12.126 | 13.248 | 12.172 | 9.922 |
| Shareholders Funds | 54.829 | 58.046 | 53.483 | 45.431 | 34.792 | 29.703 | 29.225 | 28.324 | 27.024 | 27.162 |
| Social Capital | 31.347 | 31.027 | 30.502 | 29.943 | 29.363 | 28.806 | 28.167 | 109.288 | 108.956 | 108.348 |
| Debts | 39.086 | 37.351 | 37.894 | 38.263 | 35.116 | 34.567 | 34.270 | 34.801 | 35.655 | 34.478 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharma S.a.